Nuclear transfer with porcine embryonic stem cells
US7371922B2 · kind B2 · utility
15Cited by
10References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2003 |
| Grant date | May 13, 2008 |
| Priority date | — |
| Expiry date | Jan 15, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2217/05
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided is a method for the production of transgenic animals, especially pigs, by the use of nuclear transfer from genetically modified or other embryonic stem cells to either enucleated oocytes which were matured in vivo or in vitro and activated or to enucleated zygotes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.